533897-93-7Relevant articles and documents
Stabilization of unique valencies of cobalt, nickel and copper by complexation with the tridentate ligand 2-(2′-pyridyl)-8-hydroxyquinoline Dedicated to Prof. George Christou, on his 60th birthday, an extraordinary and enthusiastic inorganic chemist, and the most supportive mentor i could ever ask for (GM).
Maayan, Galia,Dayagi, Yohai,Arad-Yellin, Rina,Shimon, Linda J.W.,Shanzer, Abraham
, p. 365 - 370 (2013)
The complexes of cobalt, copper and nickel ions with the known tridentate ligand 2-(2′-pyridyl)-8-hydroxyquinoline (HQP) were prepared and characterized. The structures of the complexes with Co(II), Cu(II) and Ni(III) were corroborated by crystal structure analyses. The structures of the complexes with Co(III) and Cu(I) were realized from NMR measurements in solution. It was found that HQP stabilizes high oxidation states of the complexed metal ions. The results also suggest that HQP binds Cu(II) and Cu(I) in two different modes; Cu(II) forms an octahedral complex with the three elements of the ligand, namely, the 8-hydroxyl the two nitrogens of bipyridine, while Cu(I) binds only to two nitrogens of the bipyridine, yielding a tetra-coordinated complex.
Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
-
Page 68, (2010/02/06)
Compounds that are dual aP2/k-FABP inhibitors are provided having the formula wherein A, B, X, Y, R1, R2 and R3 are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing dual aP2/k-FABP inhibitors alone or in combination with at least one other antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.